nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axis
|
Diao, Biyu |
|
|
211 |
3 |
p. 727-741 |
artikel |
2 |
Biology, care, and outcomes of gestational breast cancers: a review
|
Duggirala, Niharika |
|
|
211 |
3 |
p. 547-559 |
artikel |
3 |
Body composition as a potential biomarker of recurrence risk in patients with triple-negative breast cancer
|
De Vis, Jill B. |
|
|
211 |
3 |
p. 627-635 |
artikel |
4 |
Clinical treatment score post-5 years and survival benefit from extended endocrine therapy for breast cancer patients under and over 50 years of age
|
Ahn, Jee Hyun |
|
|
211 |
3 |
p. 657-667 |
artikel |
5 |
Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer
|
Turkoglu, Ezgi |
|
|
211 |
3 |
p. 743-752 |
artikel |
6 |
Correction: Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer
|
Isik, Burce |
|
|
211 |
3 |
p. 759 |
artikel |
7 |
Correction: Taxane/anthracycline combinations reduced incidence of breast cancer recurrence in young women across molecular subtypes: a real-world evidence of Taiwan from 2011 to 2019
|
Chien, Yu-Ning |
|
|
211 |
3 |
p. 755-757 |
artikel |
8 |
Critical appraisal of a data mining model for predicting nodal response to neoadjuvant treatment in breast cancer
|
Venkataraman, Janhavi |
|
|
211 |
3 |
p. 753-754 |
artikel |
9 |
Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation
|
Zhang, Chenxing |
|
|
211 |
3 |
p. 637-648 |
artikel |
10 |
Evaluating the impact of histological vs. nuclear grading on CPS + EG Score for HR + /HER2-early breast cancer
|
Braun, M. |
|
|
211 |
3 |
p. 699-704 |
artikel |
11 |
Identifying gene expression predictive of response to neoadjuvant endocrine therapy in early breast cancer
|
Hidaka, Kaori |
|
|
211 |
3 |
p. 717-725 |
artikel |
12 |
Identifying the potential mediators of pathological complete response to neoadjuvant chemotherapy among TACR1 gene polymorphisms: a study on breast cancer patients
|
Ghorbani, Marziyeh |
|
|
211 |
3 |
p. 617-626 |
artikel |
13 |
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay
|
Nikseresht, S. |
|
|
211 |
3 |
p. 605-615 |
artikel |
14 |
Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features
|
Buzatto, I. P. C. |
|
|
211 |
3 |
p. 581-593 |
artikel |
15 |
Mitochondrial tRNA fragment, mt-tRF-Tyr-GTA-001 (tRF-21-X3OJI8EWB), in breast cancer and its potential clinical implications
|
Wang, Junlong |
|
|
211 |
3 |
p. 675-685 |
artikel |
16 |
Population attributable risk of a competing-risk model for breast cancer and non-breast cancer death among women ≥ 65 years
|
Schonberg, Mara A. |
|
|
211 |
3 |
p. 687-698 |
artikel |
17 |
Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy
|
Liu, Huimin |
|
|
211 |
3 |
p. 705-715 |
artikel |
18 |
Stable overexpression of the epithelial sodium channel alpha subunit reduces migration and proliferation in breast cancer cells
|
McQueen, Sarah R. A. |
|
|
211 |
3 |
p. 595-604 |
artikel |
19 |
Targeting breast cancer: the promise of phage-based nanomedicines
|
Gholami, Sarah |
|
|
211 |
3 |
p. 561-580 |
artikel |
20 |
The effect of body mass index on breast cancer stage and breast cancer specific survival
|
Bellini, A. |
|
|
211 |
3 |
p. 649-656 |
artikel |
21 |
Timing of radiofrequency identification tag placement: can early placement save time and patient experience?
|
Newman, Ashley M. |
|
|
211 |
3 |
p. 669-674 |
artikel |